QPharma offers QLaunch, an advisory service to help companies reach commercialization
Commercial launch planning should begin early in Phase II, says the company
QPharma (Morristown, NJ), which offers a variety of consulting services, mostly in the commercial operations realm, is expanding its reach with an advisory service for clinical products. Peter Shaw, chief medical officer, says that the service is especially attuned to small- to medium-sized biopharma companies that are trying to reach the commercialization phase in drug development.
Services include recruiting, training, and managing sales teams; engaging clinical key opinion leaders; ensuring compliance with federal and state regulations; establishing programs for the management and distribution of samples; and designing and launching appropriate marketing campaigns. Shaw adds that Qpharma has relationships with a number of specialized consulting organizations that can be brought into the process; among these is Qforma (Morris Plains, NJ; which, despite its name, is separate from QPharma). Qforma has a software package called Ilaunch that is essentially a project-management tool for drug commercialization.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
